Triple Negative Breast Cancer: Nanosolutions for a Big Challenge

Triple negative breast cancer (TNBC) is a particular immunopathological subtype of breast cancer that lacks expression of estrogen and progesterone receptors (ER/PR) and amplification of the human epidermal growth factor receptor 2 (HER2) gene. Characterized by aggressive and metastatic phenotypes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Tânia Filipa S., Kluskens, Leon D., Rodrigues, Lígia Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115335/
https://www.ncbi.nlm.nih.gov/pubmed/27980912
http://dx.doi.org/10.1002/advs.201500053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115335/
https://www.ncbi.nlm.nih.gov/pubmed/27980912
http://dx.doi.org/10.1002/advs.201500053

Ejemplares similares